Drug Development – Page 9

Gilead and Cartography Collaborate to Identify Novel Antigen Targets for Cancer Therapy

1 year ago talkbio0Tagged Adenocarcinoma of lung (disorder), Antigens, Biosciences, Cancer Therapeutic Procedure, Cartography, Cervical Atlas, Drug Development, Gilead Sciences, Neoplasms, summit, targets, Technology Platform, Triple Negative Breast Neoplasms

Gilead Sciences, Cartography Biosciences, cancer therapy, antigen targets, triple-negative breast cancer, lung adenocarcinoma, ATLAS platform, SUMMIT platform, oncology, drug development.

J&J Adjusts Dosing Strategy for Actinium Prostate Cancer Drug Following Early Study Setbacks

1 year ago talkbio0Tagged Actinium, Cancer Therapeutic Procedure, Cessation of life, Clinical Trials, dosing, Drug Development, Flexible, J&J, Johnson & Johnson, Malignant neoplasm of prostate

J&J, Johnson & Johnson, actinium prostate cancer drug, capped dosing, flexible dosing, patient deaths, early study, clinical trial, cancer treatment, drug development.

Tango Pauses Clinical Trials of Promising Solid Tumor Treatment Due to Liver Toxicity Concerns

1 year ago talkbio0Tagged ARNT gene, aspects of adverse effects, Cancer Research, Clinical Trials, Drug Development, Liver, solid tumor treatment, Toxicity aspects

Tango Therapeutics, solid tumor treatment, clinical trials, liver toxicity, drug development, cancer research, treatment side effects, patient safety.

Bicycle Therapeutics Gears Up for Future Milestones with $555 Million Capital Infusion

1 year ago talkbio0Tagged Bicycle, Biotechnology, Capital, Catalyst, Clinical Trials, Drug Development, Infusion procedures, investors, milestones

Bicycle Therapeutics, funding, catalysts, biotechnology, drug development, clinical trials, investors, capital infusion, milestones.

Palisade Biotechnology’s Novel Ulcerative Colitis Treatment Shows Promising Results in Preclinical Studies

1 year ago talkbio0Tagged Canis familiaris, Drug Development, House mice, Inflammatory Bowel Diseases, Nontoxic, Palisade Biotechnology, preclinical studies, Symptoms aspect, Ulcerative Colitis

Palisade Biotechnology, ulcerative colitis, preclinical studies, nontoxic, mice, dogs, drug development, inflammatory bowel disease, treatment, prevention, symptoms

Otsuka Discontinues Alzheimer’s Agitation Drug Development Following Second Unsuccessful Trial

1 year ago talkbio0Tagged Agitation, Alzheimer 's disease, Clinical Trials, Discontinuation (procedure), Drug Development, Failed, Otsuka, trials

Otsuka, Alzheimer’s disease, agitation, drug development, clinical trials, failed trials, discontinuation

Biogen Expands Immunology Portfolio with $1.15 Billion Acquisition of HI-Bio

1 year ago talkbio0Tagged Acquisition (action), Biogen, Drug Development, expansion, HI-Bio, Immunology

Biogen, HI-Bio, acquisition, immunology, $1.15 billion, expansion, therapeutics, drug development

AstraZeneca’s Ambitious Vision: Pursuing $80 Billion in Revenue and 20 New Drugs by 2030

1 year ago talkbio0Tagged AstraZeneca, Biotechnology, Drug Development, Drug Industry, expansion, growth strategy, healthcare innovation, Market

AstraZeneca, revenue target, new drugs, 2030, growth strategy, pharmaceutical industry, healthcare innovation, biotechnology, drug development, market expansion.